122
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

The Impact of Provider Communication on Prescription Opioid Use: A Case Report

&
Pages 78-81 | Received 07 Jun 2021, Accepted 30 Oct 2022, Published online: 16 Nov 2022

References

  • Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death 1999-2019 on CDC WONDER Online Database, released 12/2020.
  • Higgins C, Smith BH, Matthews K. Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis. Br J Anaesth. 2018;120(6):1335–44. doi:10.1016/j.bja.2018.03.009
  • Matthias MS, Parpart AL, Nyland KA, Huffman MA, Stubbs DL, Sargent C, Bair MJ. The patient–provider relationship in chronic pain care: providers’ perspectives. Pain Med. 2010;11(11):1688–97. doi:10.1111/j.1526-4637.2010.00980.x
  • Cooper S, Nielsen S. Stigma and social support in pharmaceutical opioid treatment populations: a scoping review. Int J Ment Health Addict. 2017;15(2):452–69. doi:10.1007/s11469-016-9719-6
  • Brunkow A, Cannon M, Graff FS, Martin JL, Hausmann LRM, McAndrew LM. Doctor recommendations are related to patient interest and use of behavioral treatment for chronic pain and addiction. J Pain. 2020;21(9–10):979–87. doi:10.1016/j.jpain.2019.12.008
  • Matthias MS, Johnson NL, Shields CG, Bair MJ, MacKie P, Huffman M, Alexander SC. I'm not gonna pull the rug out from under you": patient-provider communication about opioid tapering. J Pain. 2017;18(11):1365–73. doi:10.1016/j.jpain.2017.06.008
  • Patel E, Pevnick JM, Kennelty KA. Pharmacists and medication reconciliation: a review of recent literature. Integr Pharm Res Pract. 2019;8:39–45. doi:10.2147/IPRP.S169727
  • Hartung DM, Hall J, Haverly SN, Cameron D, Alley L, Hildebran C, O'Kane N, Cohen D. Pharmacists’ role in opioid safety: a focus group investigation. Pain Med. 2018;19(9):1799–806. doi:10.1093/pm/pnx139
  • Rao D, Giannetti V, Kamal KM, Covvey JR, Tomko JR. Pharmacist views regarding the prescription opioid epidemic. Subst Use Misuse. 2021;56(14):2096–105. doi:10.1080/10826084.2021.1968434
  • Vadiei N, Eldridge LA, Meyerson BE, Agley J. “The gatekeepers in prevention”: community pharmacist perceptions of their role in the opioid epidemic. Subst Abus. 2022;43(1):319–27. doi:10.1080/08897077.2021.1941516

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.